Co-Authors
This is a "connection" page, showing publications co-authored by Avinash Kaur and KEITH WEBSTER.
Connection Strength
0.287
-
Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody. Gene Ther. 2024 Nov; 31(11-12):587-593.
Score: 0.062
-
Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy. Int J Mol Sci. 2024 Sep 01; 25(17).
Score: 0.061
-
Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice. Biomedicines. 2023 Jul 06; 11(7).
Score: 0.057
-
Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy. Int J Mol Sci. 2023 Jun 23; 24(13).
Score: 0.057
-
Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization. FASEB J. 2022 01; 36(1):e22106.
Score: 0.051